Key facts
- This page summarizes Daniel J. Levangie's Form 4 filing for EXACT SCIENCES CORP (EXAS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Jun 2025, 17:30.
Daniel J. Levangie - 12 Jun 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)
- Reporting relationship
- Director
- Issuer ticker
- EXAS
- Reported as of
- 12 Jun 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2025, 17:30:09 UTC
- Prior SEC filing
- 20 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel J. Levangie by Mark Busch, attorney-in- fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel J. Levangie filed Form 4 for EXACT SCIENCES CORP (EXAS) on 16 Jun 2025.
Change
- Previous filing in this sequence was filed on 20 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001187406
Primary reporting owner
LEVANGIE DANIEL J
- Relationship
- Director
- Address
- C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON
- Signature
- /s/ Daniel J. Levangie by Mark Busch, attorney-in- fact
- Signature date
- 16 Jun 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXAS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,398
- Change %
- +19%
- Price
- $0.000000
- Shares after
- 34,312
- Date
- 12 Jun 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy.
SEC remarks
Exhibit 24 - Power of Attorney